Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Final beam laid for new BioEscalator/Novo Nordisk Building, due to open Summer 2018

Image courtesy of Tony Brett

Last week a topping out ceremony was held at the BioEscalator/ Novo Nordisk Building at Old Road Campus to celebrate its final beams being laid. The building will house the Oxford BioEscalator and Novo Nordisk Research Centre Oxford (NNRCO) when it opens in Summer 2018. 

An incredible 15,000 tons of steel work, 3,000 bolts, 5,700 tons of concrete, 423 parking spaces, and 183,000 man hours with no reportable accidents have gone into creating the building and its 2,800mof labspace and offices. 

Elen Wade-Martins, Business Manager for the BioEscalator, and Jim Johnson, Head of the NNRCO, tightened the final bolts on the building and celebrated their vision for the future of the space. 

Novo Nordisk/ Bioescalator topping out

Elen Wade-Martins and Jim Johnson at the Topping Out Ceremony. Photo by David Fleming. 

Elen Wade-Martins commented: 'The BioEscalator will help early stage bioscience companies to overcome obstacles to become sustainable businesses, and enable more of the exciting medical innovation in our labs at the University to make it to the clinic.' 

Jim Johnson expects: 'The new building will be a hub of innovation and collaboration where fundamental biological discoveries are made and translated towards therapeutics for the ultimate benefit of the patients we are dedicated to helping.' 

 

 

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.